November 2019: CBD for the Reduction of Craving and Anxiety in Heroin Use Disorder [lCI_5z6rJVY]

November 2019: CBD for the Reduction of Craving and Anxiety in Heroin Use Disorder [lCI_5z6rJVY]

| 1h 28m 28s | Video has closed captioning.

Executive Editor Michael Roy speaks with Yasmin Hurd, Ph.D., about her research on the potential of cannabidiol (CBD) to reduce cue-induced craving and anxiety, two critical features of addiction that often contribute to relapse and continued drug use, in drug-abstinent individuals with heroin use disorder. Read the article: What has past research with CBD shown in terms of its function as a treatment for mental illness? [2:29] Why the present study examined the potential of CBD to moderate craving and anxiety, and how these reactions were triggered among participants [4:14] How did the study team decide to evaluate CBD at two different doses? [5:54] Main findings of the study [7:42] Discussion of secondary outcomes and adverse events [9:02] Take-home messages for mental health professionals and the general public [11:37] Thoughts on how the medical use of CBD will fit in to the broader trend of the relaxation of marijuana laws throughout the United States [13:28] Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Play, Stitcher, Spotify, or wherever you listen to it. Subscribe here: Listen to other podcasts produced by the American Psychiatric Association: Browse articles online: Also visit the online edition of this month’s Journal to watch a video of Deputy Editor Daniel S. Pine, M.D., present highlights from the issue: Follow the Journal on Twitter: E-mail us at ajp@psych.org